Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological ...

First full post acquisition quarter builds momentum for 2026 (Dignitana has been part of the group since June 1. Figures in parentheses refer to the outcome for the corresponding period of the previou ...

BOSTON, Nov. 14, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid (R) Bone-Anchored Annular Closure Device, announced today the first endoscopic Barricaid implantation in ...

Milestone Scientific Inc (MLSS) reports stable revenue with significant operating expense reductions and strategic ...

Strata Skin Sciences (($SSKN)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for Strata ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025. "Over the last year, we have taken ...

Integrating Nym AI requires a clear plan that looks at both the technology and the people involved. By assessing current ...

Bionano Genomics, Inc. (NASDAQ: BNGO) Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats ...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 27 years, gives his ...

Aetna’s new “level of severity inpatient payment” policy is now set to take effect Jan. 1, 2026, the company recently announced, along with providing additional details about the policy. The policy ...

Earlier this year, researchers at CHOP and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a rare liver disorder. KJ Muldoon ...